Pfizer withdraws application for emergency use of its Covid-19 vaccine in India

Created on 2021-02-21T23:52:47-06:00

Return to the Index

This card pertains to a resource available on the internet.

This card can also be read via Gemini.

Pfizer has withdrawn an application for emergency-use authorization of its Covid-19 vaccine in India that it has developed with Germany’s BioNTech, the company told Reuters on Friday.
India’s Central Drugs Standard Control Organization had declined to accept Pfizer’s request for approval without a small local trial on the vaccine’s safety and immunogenicity for Indians, Reuters has reported.